Active Apical Secretory Efflux of the HIV Protease Inhibitors Saquinavir and Ritonavir in Caco-2 Cell Monolayers

被引：0

作者：

Jochem Alsenz

Hans Steffen

Rainer Alex

机构：

[1] F. Hoffmann-La Roche Ltd,Preclinical Research Department, Pharma Division

[2] Grenzacherstrasse,undefined

[3] F. Hoffmann-La Roche Ltd.,undefined

[4] Grenzacherstrasse,undefined

来源：

Pharmaceutical Research | 1998年 / 15卷

关键词：

HIV protease inhibitors; saquinavir; ritonavir; Caco-2 cells; efflux system;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

Purpose. To investigate in vitro the mechanisms involved in the gastrointestinal absorption of the HIV protease inhibitor, saquinavir mesylate (Invirase®), whose oral bioavailability is low, variable, and significantly increased by co-administration with ritonavir, also an HIV protease inhibitor but with higher oral bioavailability.

引用

页码：423 / 428

页数：5

共 50 条

[1] Active apical secretory efflux of the HIV protease inhibitors saquinavir and ritonavir in Caco-2 cell monolayers
Alsenz, J
Steffen, H
Alex, R
PHARMACEUTICAL RESEARCH, 1998, 15 (03) : 423 - 428
[2] Active apical secretory efflux of the HIV protease inhibitors saquinavir and ritonavir in Caco-2 cell monolayers. (vol 15, pg 423, 1998)
Alsenz, J
Steffen, H
Alex, R
PHARMACEUTICAL RESEARCH, 1998, 15 (06) : 958 - 958
[3] Transepithelial Transport of Prodrugs of the HIV Protease Inhibitors Saquinavir, Indinavir, and Nelfinavir Across Caco-2 Cell Monolayers
Marielle Rouquayrol
Bérangère Gaucher
Dominique Roche
Jacques Greiner
Pierre Vierling
Pharmaceutical Research, 2002, 19 : 1704 - 1712
[4] Transepithelial transport of prodrugs of the HIV protease inhibitors saquinavir, indinavir, and nelfinavir across Caco-2 cell monolayers
Rouquayrol, M
Gaucher, B
Roche, D
Greiner, J
Vierling, P
PHARMACEUTICAL RESEARCH, 2002, 19 (11) : 1704 - 1712
[5] Absorptive and Secretory Transport of Across Caco-2 Cell Monolayers
Heyns, Jaco
Willers, Clarissa
Haynes, Richard K.
Wong, Ho N.
Hamman, Josias
Gouws, Chrisna
CURRENT DRUG DELIVERY, 2018, 15 (08) : 1183 - 1192
[6] Clinical pharmacology of HIV protease inhibitors: focus on saquinavir, indinavir, and ritonavir
R.M.W. Hoetelmans
C.H.W. Koks
J.H. Beijnen
P.L. Meenhorst
J.W. Mulder
D.M. Burger
Pharmacy World and Science, 1997, 19 : 159 - 175
[7] Clinical pharmacology of HIV protease inhibitors: focus on saquinavir, indinavir, and ritonavir
Hoetelmans, RMW
Meenhorst, PL
Mulder, JW
Burger, DM
Koks, CHW
Beijnen, JH
PHARMACY WORLD & SCIENCE, 1997, 19 (04): : 159 - 175
[8] Effects of acylcarnitines on efflux transporting system in Caco-2 cell monolayers
Tomita, Mikio
Doi, Nobuyuki
Hayashi, Masahiro
EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS, 2010, 35 (1-2) : 1 - 7
[9] Effects of acylcarnitines on efflux transporting system in Caco-2 cell monolayers
Mikio Tomita
Nobuyuki Doi
Masahiro Hayashi
European Journal of Drug Metabolism and Pharmacokinetics, 2010, 35 : 1 - 7
[10] Modulation of P-glycoprotein function in human lymphocytes and Caco-2 cell monolayers by HIV-1 protease inhibitors
Profit, L
Eagling, VA
Back, DJ
AIDS, 1999, 13 (13) : 1623 - 1627

← 1 2 3 4 5 →